|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 107, Issue 12 3363-3377, Copyright © 1994 by Company of Biologists
JOURNAL ARTICLES |
BT Gjertsen, LI Cressey, S Ruchaud, G Houge, M Lanotte and SO Doskeland
University of Bergen, Medical School, Department of Anatomy and Cell Biology, Norway.
The protein phosphatase inhibitors okadaic acid and calyculin A at moderate concentrations induced three types of apoptotic promyelocytic leukemia cell death, distinct with respect to ultrastructure and polynucleotide fragmentation. Calyculin A at higher concentrations (> 50 nM) induced a non-apoptotic death type with high ATP and pronounced micromitochondriosis. This suggests that protein phosphorylation pathways are involved in the triggering of several death pathways. Activation of the cAMP kinase induced yet another apoptotic death type, preferentially affecting cells in S-phase. In fact, cAMP acted in two ways to stop IPC promyelocyte proliferation: (1) block in late G1 (preventing new cells from entering DNA replication); and (2) induction of apoptosis in S-phase. cAMP and phosphatase inhibitors acted via distinct pathways. The inhibitors suppressed cAMP-induced death, but only at concentrations high enough to commit the cells to alternative, less conspicuous death types. The tumor-promoting activity of okadaic acid and calyculin A may therefore not be by protection against apoptosis. DNA fragmentation correlated with the novel feature of limited 28 S rRNA cleavage, suggesting co-ordinated polynucleotide cleavage, possibly directed against illegitimate polynucleotides, in some apoptotic death types.
This article has been cited by other articles:
|
|
 |
|
  S. C. Fausch, L. M. Fahey, D. M. Da Silva, and W. M. Kast Human Papillomavirus Can Escape Immune Recognition through Langerhans Cell Phosphoinositide 3-Kinase Activation J. Immunol., June 1, 2005; 174(11): 7172 - 7178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Anderson, W. Alrefai, P. Bonomi, T. M. Seed, P. Dudeja, Y. Hu, and J. E. Harris Caspase-Dependent and -Independent Panc-1 Cell Death Due to Actinomycin D and MK 886 Are Additive but Increase Clonogenic Survival Experimental Biology and Medicine, September 1, 2003; 228(8): 915 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sandal, L. Aumo, L. Hedin, B. T. Gjertsen, and S. O. Doskeland Irod/Ian5: An Inhibitor of {gamma}-Radiation- and Okadaic Acid-induced Apoptosis Mol. Biol. Cell, August 1, 2003; 14(8): 3292 - 3304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Refsnes, P. E Schwarze, J. A Holme, and M. Laeg Fluoride-induced apoptosis in human epithelial lung cells (A549 cells): role of different G protein-linked signal systems Human and Experimental Toxicology, March 1, 2003; 22(3): 111 - 123. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Sandal, C. Stapnes, H. Kleivdal, L. Hedin, and S. O. Doskeland A Novel, Extraneuronal Role for Cyclin-dependent Protein Kinase 5 (CDK5). MODULATION OF cAMP-INDUCED APOPTOSIS IN RAT LEUKEMIA CELLS J. Biol. Chem., May 31, 2002; 277(23): 20783 - 20793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Leicht, W. Briest, A. Holzl, and H.-G. Zimmer Serum depletion induces cell loss of rat cardiac fibroblasts and increased expression of extracellular matrix proteins in surviving cells Cardiovasc Res, December 1, 2001; 52(3): 429 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Barriere, C. Poujeol, M. Tauc, J. M. Blasi, L. Counillon, and P. Poujeol CFTR modulates programmed cell death by decreasing intracellular pH in Chinese hamster lung fibroblasts Am J Physiol Cell Physiol, September 1, 2001; 281(3): C810 - C824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Anderson and J. E. Harris Selected Features of Nonendocrine Pancreatic Cancer Experimental Biology and Medicine, June 1, 2001; 226(6): 521 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Bruserud, B. T. Gjertsen, B. Foss, and T.-S. Huang New Strategies in the Treatment of Acute Myelogenous Leukemia (AML): In Vitro Culture of AML Cells--The Present Use in Experimental Studies and the Possible Importance for Future Therapeutic Approaches Stem Cells, January 1, 2001; 19(1): 1 - 11. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. M. Marcic and E. G. Erdös Protein Kinase C and Phosphatase Inhibitors Block the Ability of Angiotensin I-Converting Enzyme Inhibitors to Resensitize the Receptor to Bradykinin without Altering the Primary Effects of Bradykinin J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 605 - 612. [Abstract] [Full Text]
|
|
|
|
|
|
J. Tian and M. Karin Stimulation of Elk1 Transcriptional Activity by Mitogen-activated Protein Kinases Is Negatively Regulated by Protein Phosphatase 2B (Calcineurin) J. Biol. Chem., May 21, 1999; 274(21): 15173 - 15180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mills, V. Lee, and R. Pittman Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis J. Cell Sci., January 3, 1998; 111(5): 625 - 636. [Abstract] [PDF]
|
|
|
|
|
|
K. E. Fladmark, O. T. Brustugun, G. Mellgren, C. Krakstad, R. Boe, O. K. Vintermyr, H. Schulman, and S. O. Doskeland Ca2+/Calmodulin-dependent Protein Kinase II Is Required for Microcystin-induced Apoptosis J. Biol. Chem., January 18, 2002; 277(4): 2804 - 2811. [Abstract] [Full Text] [PDF]
|
|
